Lima et al. have shown that elevated O-GlcNAc levels contribute to end-organ damage and vasoconstriction under diabetes, concurrent with decreased eNOS (Ser1177) and Akt phosphorylation (Ser473) [121]. This evidence concerns the gene AKT1 and diabetes mellitus.